Free Trial
NYSEAMERICAN:AST

Asterias Biotherapeutics (AST) Stock Price, News & Analysis

Asterias Biotherapeutics logo
$0.0020 0.00 (0.00%)
As of 07/10/2019

About Asterias Biotherapeutics Stock (NYSEAMERICAN:AST)

Key Stats

Today's Range
$0.0020
$0.0020
50-Day Range
N/A
52-Week Range
$0.51
$2.05
Volume
1,000 shs
Average Volume
136,653 shs
Market Capitalization
$111.32 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Asterias Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

AST Stock News Headlines

ARTV Artiva Biotherapeutics, Inc.
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
CLDI Calidi Biotherapeutics, Inc.
Protalix BioTherapeutics Inc PLX
See More Headlines

AST Stock Analysis - Frequently Asked Questions

Asterias Biotherapeutics' stock was trading at $0.0020 at the beginning of the year. Since then, AST shares have increased by 0.0% and is now trading at $0.0020.

Asterias Biotherapeutics Inc (NYSEAMERICAN:AST) released its earnings results on Tuesday, March, 28th. The biotechnology company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.01. The biotechnology company earned $1.75 million during the quarter, compared to analysts' expectations of $2.81 million.

Shares of AST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Asterias Biotherapeutics investors own include Zynerba Pharmaceuticals (ZYNE), CorMedix (CRMD), Synergy Pharmaceuticals (SGYP), 22nd Century Group (XXII), Amarin (AMRN), Gilead Sciences (GILD) and Progenics Pharmaceuticals (PGNX).

Company Calendar

Last Earnings
3/28/2017
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:AST
Previous Symbol
NYSEMKT:AST
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$111.32 thousand
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSEAMERICAN:AST) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners